Skip to main content
McKesson Corporation
Healthcare · Medical Distribution
Made on Aug 18, 2026
Price at call $859.92
6-month call Bull +11.1%
Target by Feb 2027 $955.00
Great value below $820.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change +11.1% to $955.00
Predicted High $955.00 at 6 months
Predicted Low $862.50 in 2 weeks

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 18, 2026 3:09 am
Bull MCK trends higher to $955.00 (+11.1% from $859.92) by Feb 2027. dip-then-recover
ThesisMCK trades below composite fair value with steady earnings beats and defensive characteristics, but risk-on tape and opioid overhang cap near-term upside. Expect gradual mean reversion toward baseline over 6 months, with modest early drift and firmer convergence as value gravity dominates.
Invalidated ifBreak below $820 support or new opioid liability headline; failure to reclaim $900 by month 3
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $859.92 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 18, 2026 $859.92 at call The anchor — every point below is measured from this price and date.
2 weeks Sep 1, 2026 $807.66–$912.18 typical range · internal point $862.50 ±6.1% 6/10 Low-beta drift in risk-on tape, minimal catalyst
1 month Sep 18, 2026 $784.19–$935.65 typical range · internal point $868.00 ±8.8% 6/10 Slow grind higher as value buyers accumulate
2 months Oct 18, 2026 $885.00 +2.9% 5/10 Rotation into defensives as regime matures
3 months Nov 18, 2026 $905.00 +5.2% 5/10 Earnings beat streak reinforces compounder narrative
4 months Dec 18, 2026 $925.00 +7.6% 4/10 Value convergence toward composite fair value
5 months Jan 18, 2027 $940.00 +9.3% 4/10 Continued mean reversion, defensive bid
6 months Feb 18, 2027 $955.00 +11.1% 4/10 Approach deterministic baseline, DCF anchor pull

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $949.25 (+10.4%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

No weaknesses recorded for this run.

All inputs present, no fallbacks used — nothing to flag.

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$859.92
Composite fair value$971.98
Signal-adjusted fair value$1,150.23
DCF fair value$1,048.06
Anchored-PE fair value$1,358.47
Buy-below (value lens)$820.00
Value net score+16
Value confidence6 / 10
Quality net score+55
Memo confidence6 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 35.5%  3m 30.5%  6m 28.4%  
Daily σ (realism noise)1.9%
Beta vs S&P 500 1m -1.36  3m -1.00  5m -0.55  
Trailing 6-month return-6.5%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Aug 9, 2026 8d behind MCK-20260809-000707-2aec
ext-forensic-memo Aug 17, 2026 freshest ext-MCK-20260817-101539-f095
ext-lens-quality Aug 17, 2026 freshest ext-MCK-20260817-101539-f095
ext-lens-sentiment Aug 17, 2026 freshest ext-MCK-20260817-101539-f095
ext-lens-value Aug 17, 2026 freshest ext-MCK-20260817-101539-f095
scenario-valuation Aug 17, 2026 freshest MCK-20260809-000707-2aec
valuation-synthesis Aug 17, 2026 freshest MCK-20260809-000707-2aec

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

3 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 18, 2026 v0.6.0 Bull $859.92 $955.00 +11.1% Feb 2027 viewing
Aug 9, 2026 v0.6.0 Bull $869.58 $960.00 +10.4% Feb 2027 view
Jul 10, 2026 v0.3.0 view

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.